Zobrazeno 1 - 10
of 186
pro vyhledávání: '"Min‐Suk Yang"'
Publikováno v:
Clinical and Experimental Otorhinolaryngology, Vol 17, Iss 4, Pp 317-325 (2024)
Objectives. This study evaluates the enduring efficacy and patient satisfaction of dupilumab with interdose interval adjustments based on the Sino-Nasal Outcome Test (SNOT-22) in chronic rhinosinusitis with nasal polyps (CRSwNP). Methods. A retrospec
Externí odkaz:
https://doaj.org/article/62fb51a3000f4243a7a0192f9c3466c5
Autor:
Yu Ri Kang, MD, Hyunkyoung Kim, MS, MPH, Chae Eun Lee, BS, Jae-Woo Jung, MD, PhD, Ji-Yong Moon, MD, PhD, So Young Park, MD, MS, Sae-Hoon Kim, MD, PhD, Min-Suk Yang, MD, PhD, Byung Keun Kim, MD, PhD, Jae-Woo Kwon, MD, PhD, Hye-Kyung Park, MD, PhD, Young-Hee Nam, MD, PhD, Young-Joo Cho, MD, PhD, Taehoon Lee, MD, PhD, Ian M. Adcock, MD, PhD, Pank Bhavsar, MD, PhD, Kian Fan Chung, MD, PhD, Tae-Bum Kim, MD, PhD
Publikováno v:
World Allergy Organization Journal, Vol 18, Iss 1, Pp 100990- (2025)
Background: Eosinophils are crucial in allergic inflammation, and their correlation with asthma severity has made them a focal point in predicting treatment outcomes. Blood eosinophil count is a commonly utilized marker. However, its limitations have
Externí odkaz:
https://doaj.org/article/ff2d681417494ab083405cee9f2ee90b
Autor:
Hyo-In Rhyou, MD, PhD, Hyun-Kyoung Kim, MPH, Woo-Jung Song, MD, PhD, Sang Min Lee, MD, PhD, Sang-Ha Kim, MD, PhD, Jae-Woo Kwon, MD, PhD, Han-Ki Park, MD, PhD, Hye-Kyung Park, MD, PhD, Sang Hoon Kim, MD, PhD, Jeong-Hee Choi, MD, PhD, Sujeong Kim, MD, PhD, So-Young Park, MD, PhD, Sae-Hoon Kim, MD, PhD, Ji-Yong Moon, MD, PhD, Jae-Woo Jung, MD, PhD, Young-Joo Cho, MD, PhD, Chan Sun Park, MD, PhD, Byung Keun Kim, MD, PhD, Joo-Hee Kim, MD, PhD, Min-Suk Yang, MD, PhD, Min-Hye Kim, MD, PhD, Young-Hee Nam, MD, PhD, Taehoon Lee, MD, PhD, Byung-Jae Lee, MD, PhD, Pankaj Bhavsar, PhD, Ian M. Adcock, PhD, Kian Fan Chung, MD, DSc, Tae-Bum Kim, MD, PhD
Publikováno v:
World Allergy Organization Journal, Vol 17, Iss 9, Pp 100957- (2024)
Background: Anti-type 2 (T2) biologic therapies (biologics) improve exacerbation rates, lung function, and asthma-related quality of life (QoL) in patients with severe T2 asthma. However, studies comparing different biologics are lacking. We evaluate
Externí odkaz:
https://doaj.org/article/c3d9ee64e9d1410390ea957c7f385f40
Autor:
Ji-Su Shim, MD, PhD, Hyunkyoung Kim, MS, Jae-Woo Kwon, MD, PhD, So-Young Park, MD, PhD, Sujeong Kim, MD, PhD, Byung-Keun Kim, MD, PhD, Young-Hee Nam, MD, PhD, Min-Suk Yang, MD, PhD, Mi-Yeong Kim, MD, PhD, Sae-Hoon Kim, MD, PhD, Byung-Jae Lee, MD, PhD, Taehoon Lee, MD, PhD, Sang-Ha Kim, MD, PhD, So Young Park, MD, PhD, Young-Joo Cho, MD, PhD, Chan Sun Park, MD, PhD, Jae-Woo Jung, MD, PhD, Han-Ki Park, MD, PhD, Joo-Hee Kim, MD, PhD, Jeong-Hee Choi, MD, PhD, Ji-Yong Moon, MD, PhD, Ian Adcock, MD, PhD, Kian Fan Chung, MD, PhD, Min-Hye Kim, MD, PhD, Tae-Bum Kim, MD, PhD
Publikováno v:
World Allergy Organization Journal, Vol 16, Iss 12, Pp 100848- (2023)
Background: Despite the increasing use of biologics in severe asthma, there is limited research on their use in asthma-chronic obstructive pulmonary disease overlap (ACO). We compared real-world treatment responses to biologics in ACO and asthma. Met
Externí odkaz:
https://doaj.org/article/115a5da23baa4ea1b6b799002667e9d9
Autor:
Min-Hye Kim, MD, PhD, Dong Yoon Kang, MD, PhD, Young-Hee Nam, MD, PhD, Da Woon Sim, MD, PhD, Sujeong Kim, MD, Jun Kyu Lee, MD, PhD, Jung-Won Park, MD, PhD, Hye-Kyung Park, MD, PhD, Jae-Woo Jung, MD, PhD, Cheol-Woo Kim, MD, PhD, Min-Suk Yang, MD, PhD, Joo-Hee Kim, MD, PhD, Young-Min Ye, MD, PhD, Young-Il Koh, MD, PhD, Hye-Ryun Kang, MD, PhD, Seoung Ju Park, Sae-Hoon Kim
Publikováno v:
World Allergy Organization Journal, Vol 16, Iss 1, Pp 100738- (2023)
Background: Although beta-lactams are 1 of the major causative agents of severe cutaneous adverse reactions (SCAR), their epidemiology and clinical aspects have been poorly studied. This study aimed to investigate the characteristics of SCAR caused b
Externí odkaz:
https://doaj.org/article/bf0a08aaf1a4474fa09221597cc1c943
Autor:
Ji-Su Shim, MD, PhD, Juhae Jin, MA, Sae-Hoon Kim, MD, PhD, Taehoon Lee, MD, PhD, An-Soo Jang, MD, PhD, Chan Sun Park, MD, PhD, Jae-Woo Jung, MD, PhD, Jae-Woo Kwon, MD, PhD, Ji-Yong Moon, MD, PhD, Min-Suk Yang, MD, PhD, Jaechun Lee, MD, PhD, Jeong-Hee Choi, MD, PhD, Yoo Seob Shin, MD, PhD, Hee-Kyoo Kim, MD, PhD, Sujeong Kim, MD, PhD, Joo-Hee Kim, MD, PhD, Sang-Heon Cho, MD, PhD, Young-Hee Nam, MD, PhD, Sang-Hoon Kim, MD, PhD, So Young Park, MD, PhD, Gyu Young Hur, MD, PhD, Sang-Ha Kim, MD, PhD, Hye-Kyung Park, MD, PhD, Hyun Jung Jin, MD, PhD, Jae-Hyun Lee, MD, PhD, Jung-Won Park, MD, PhD, Ho Joo Yoon, MD, PhD, Byoung Whui Choi, MD, PhD, Young-Joo Cho, MD, PhD, Min-Hye Kim, MD, PhD, Tae-Bum Kim, MD, PhD
Publikováno v:
World Allergy Organization Journal, Vol 15, Iss 12, Pp 100720- (2022)
Background: Tiotropium, a long-acting muscarinic antagonist, is recommended for add-on therapy to inhaled corticosteroids (ICS)-long-acting beta 2 agonists (LABA) for severe asthma. However, real-world studies on the predictors of response to tiotrop
Externí odkaz:
https://doaj.org/article/60c04c3c8a25489d9427d867e569f581
Autor:
Sung-Yoon Kang, MD, PhD, Min-Suk Yang, MD, PhD, Magnus P. Borres, MD, PhD, Mats Andersson, MSc, Sang Min Lee, MD, PhD, Sang Pyo Lee, MD, PhD
Publikováno v:
World Allergy Organization Journal, Vol 15, Iss 11, Pp 100709- (2022)
Background: Component resolved diagnostics (CRD) in dog and cat allergy is not sufficiently investigated, especially regarding new components such as Can f 4, Can f 6, and Fel d 7. The purpose of this study is to evaluate the potential role of CRD wi
Externí odkaz:
https://doaj.org/article/9eec7a31e9be404a85f4ad8698fc453d
Autor:
Mi‐Yeong Kim, James Yun, Dong‐Yoon Kang, Tae Hee Kim, Min‐Kyung Oh, Sunggun Lee, Min‐Gyu Kang, Young‐Hee Nam, Jeong‐Hee Choi, Min‐Suk Yang, Seung Seok Han, Hajeong Lee, Hyun‐Jai Cho, Jaeseok Yang, Kook‐Hwan Oh, Yon Su Kim, Jae Woo Jung, Kye Hwa Lee, Hye‐Ryun Kang
Publikováno v:
Clinical and Translational Allergy, Vol 12, Iss 9, Pp n/a-n/a (2022)
Abstract Background HLA‐B*58:01 is a well‐known risk factor for allopurinol‐induced severe cutaneous adverse reactions (SCARs). However, only a minority of HLA‐B*58:01 carriers suffer SCARs after taking allopurinol. The aim of this study was
Externí odkaz:
https://doaj.org/article/3b1d19c4096942fca29e699d106fa912
Autor:
Hye Jung Park, Sae-Hoon Kim, Yoo Seob Shin, Chul Hwan Park, Eun-Suk Cho, Seung Joon Choi, So Hyun Park, Joo Hyun Jung, Il Gyu Kang, Myoung Seok Lee, Dae Woo Kim, Sang Min Lee, Min-Suk Yang, Sang Pyo Lee
Publikováno v:
Respiratory Research, Vol 22, Iss 1, Pp 1-13 (2021)
Abstract Background Most previous studies used aluminum hydroxide-absorbed allergen extracts in evaluating the potential therapeutic roles of intralymphatic allergen-specific immunotherapy (ILAIT). In this study, we evaluated the therapeutic efficacy
Externí odkaz:
https://doaj.org/article/926f4523865d43d59dafbc69c802f202
Autor:
Tsugumichi Sato, Ching‐Lan Cheng, Heung‐Woo Park, Yea‐Huei Kao Yang, Min‐Suk Yang, Mizuki Fujita, Yuji Kumagai, Masahiro Tohkin, Yoshiro Saito, Kimie Sai
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 3, Pp 1002-1014 (2021)
Abstract Allopurinol‐related severe cutaneous adverse reactions (SCARs) are strongly associated with HLA‐B*58:01, the allele frequency (AF) of which is largely different among East Asians. However, evidence of population differences in SCAR devel
Externí odkaz:
https://doaj.org/article/5109b92371bd4a9e84d62cd12081cbd2